Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
90,438,636
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
56,683,321
-
Shares change
-
-1,243,138
-
Total reported value, excl. options
-
$3,701,432,142
-
Value change
-
-$78,744,860
-
Put/Call ratio
-
94%
-
Number of buys
-
171
-
Number of sells
-
161
-
Price
-
$65.35
Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP) as of Q3 2022
As of 30 Sep 2022 CRISPR Therapeutics AG - Common Stock (CRSP) had 410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,683,321 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, Capital International Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., BlackRock Inc., T. Rowe Price Investment Management, Inc., FMR LLC, NEA Management Company, LLC, STATE STREET CORP, and BANK OF AMERICA CORP /DE/.
This table shows 410 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.